Kevin Dunivan, NP
Acute Care · Chester, VANPI 1346762440
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,224 of the $3,117 with a category attached, or 71.3%. 27 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 34.4% of the total. Among acute care clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $35.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Boston Scientific$530
- Vertex$145
- AbbVie$139
- Stryker$135
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$133
- plus $965 from 21 others
What the payments were for
- Travel & lodging$89329%
- Food & beverage$2,22471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 9 | $1,071 |
| Boston Scientific | 9 | $530 |
| Vertex | 7 | $145 |
| AbbVie | 10 | $139 |
| Stryker | 1 | $135 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $133 |
| Collegium Pharmaceutical, Inc. | 5 | $103 |
| Scilex Pharmaceuticals Inc. | 5 | $90 |
| Averitas Pharma Inc. | 4 | $84 |
| Globus Medical | 2 | $78 |
| IBSA Pharma Inc. | 3 | $73 |
| Si-bone, Inc. | 2 | $64 |
| Pfizer | 3 | $60 |
| Amgen | 3 | $53 |
| SPR Therapeutics, Inc | 2 | $42 |
| Fidia Pharma USA Inc. | 2 | $41 |
| Abbott | 2 | $41 |
| Nevro Corp. | 2 | $37 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Cumberland Pharmaceuticals, Inc. | 1 | $30 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| Lundbeck LLC | 1 | $22 |
| Avanos Medical | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Medtronic | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Lenoss Medical Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$893
- WaveWriter Alpha Prime 16$338
- SPINEJACK$135
How this compares
$3,117 in reported general payments places this provider in the 90th percentile of 599 acute care providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZtlidoLidocaine | 17 | $9,178 |
| Lidocaine | 30 | $3,491 |
| Gabapentin | 150 | $2,596 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 124 | $2,516 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 115 | $2,346 |
| Oxycodone Hcl | 58 | $2,211 |
| Pregabalin | 124 | $2,122 |
| Duloxetine Hcl | 62 | $1,712 |
| Naloxone Hcl | 21 | $1,208 |
| Methocarbamol | 68 | $773 |
| Cyclobenzaprine Hcl | 95 | $765 |
| Morphine Sulfate ErMorphine Sulfate | 31 | $698 |
| Diclofenac Sodium | 46 | $652 |
| Tizanidine Hcl | 77 | $531 |
| Celecoxib | 23 | $473 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Scilex Pharmaceuticals Inc.Ztlido | $90 | $9,17817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 599 acute care providers in Virginia.
Other acute care in Chester
- Rachel DukeRichmond$751K
- Julia KingNorfolk$99K
- Sarah KennedyNorfolk$57K
- Sarah W ShermanNorth Chesterfield$41K
- Tamara StephensDeltaville$30K
- Debra CastnerNassawadox$28K
- Linda HartMidlothian$21K
- Mica FerlisRichmond$20K
- Corinnia WagnerFredericksburg$18K
- Tonja StevensArlington$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.